MAPT and Alzheimer disease: 1) AD models: Animal models of AD, such as transgenic mice expressing amyloid precursor protein (APP) and presenilin mutations, have been used to study the therapeutic effects of EVs on Aβ pathology, tau pathology, synaptic dysfunction, and cognitive impairment.